CINtec® PLUS Immunocytochemical Diagnosis of Cervical Precancerous Lesions – New at “Synevo”

09/01/2026

CINtec+ Immunocytochemistry – a dual predictive screening test that assesses the risk of developing precancerous cervical epithelial conditions

CINtec+ immunocytochemistry is performed on all women who:

– Low-grade cervical epithelial neoplasia (CIN2) was detected

– High-risk types of HPV human papillomavirus identified

Sample collection is performed using a vial and brush designed for liquid-based cytology, which allows for loss-free collection and undamaged transportation of the material.

In addition, with the collected material it will be possible to simultaneously carry out:

– Pap test using liquid cytology method

– HPV genotyping

– CINtec+ immunocytochemical study

Learn more

Follow our social pages and learn more

https://synevo.ge/news-and-promotions/

n.manjaparashvili@synevo.ge

CINtec​​®​ PLUS Immunocytochemical Diagnosis of Cervical Precancerous Lesions – New at “Synevo”

CINtec® PLUS Immunocytochemical Diagnosis of Cervical Precancerous Lesions – New at “Synevo”